In the global pharmaceutical, biotechnology, and medical technology sectors, healthcare logistics is not merely a freight movement service—it is a critical extension of product quality control and patient safety. A single temperature excursion, custom clearance hold, or improper thermal mapping can destroy millions of dollars in biopharmaceutical assets and jeopardize clinical trials or patient care timelines.
At SHIPIT Logistics®, we bring over five decades of international freight forwarding rigor, federal licensing, and specialized Good Distribution Practice (GDP) protocols to healthcare procurement teams worldwide. Founded in 1974 as American Export Lines, our organization combines hands-on trade lane expertise with advanced thermal management technologies, ensuring your active pharmaceutical ingredients (APIs), finished formulations, cell therapies, and diagnostic devices move globally without risk.
“Healthcare freight forwarding demands uncompromised compliance, continuous thermal telemetry, and absolute operational transparency. We protect the integrity of life-saving science.”
From temperature-sensitive biopharmaceuticals to capital medical equipment, our specialized healthcare logistics services are engineered to meet strict international quality and thermal standards.
Designed for Cell & Gene Therapies (CGT), mRNA vaccines, and viral vectors utilizing liquid nitrogen (LN2) dry shippers and dry ice replenishment protocols with continuous telemetry monitoring.
Explore Air SolutionsActive temperature-controlled ocean reefer containers and thermistor-monitored air cargo solutions for high-volume commercial drugs, plasma proteins, and oral solid dosages.
Time-critical global distribution of Investigational Medicinal Products (IMPs), placebos, lab kits, and biological samples with Direct-to-Patient (DTP) white-glove delivery options.
Clinical SolutionsWhite-glove, shock-monitored, air-ride transportation for MRI scanners, surgical robotics, and diagnostic reagents requiring specialized uncrating and climate-controlled staging.
Certified under IATA, IMDG, and DOT 49 CFR regulations for handling infectious substances, biological specimens, dry ice packaging, and lithium-battery-powered medical devices.
Hazmat ComplianceLicensed US customs brokers managing FDA Product Codes, Import Alerts, Prior Notice filings, USDA quotas, and DEA permits to prevent expensive clearance delays at ports of entry.
Customs BrokerageTemperature-mapped facilities in Los Angeles and East Coast hubs offering ambient, refrigerated, and freezer storage, transloading, and emergency re-icing services.
Dedicated air charter services and NFO priority routes for urgent pandemic response, organ transportation, organoid preservation, and high-value biotech shipments.
Charter ServicesAs advanced therapeutics rise and global regulations tighten, healthcare supply chains are undergoing a fundamental structural transformation. Procurement leaders must align with modern logistics paradigms.
Unlike traditional small-molecule pharmaceuticals which remain stable under ambient conditions, modern biopharmaceuticals—such as monoclonal antibodies, cell therapies, gene therapies, and mRNA-based products—are highly sensitive to thermal fluctuations and shear stress. This shift requires healthcare logistics providers to transition from simple transport to validated, zero-excursion cold chain ecosystems.
Regulatory bodies such as the US FDA, European Medicines Agency (EMA), and Health Canada are enforcing strict GDP rules for non-active pharmaceutical ingredients and finished products. Thermal profiling of trade routes, ambient temperature mapping, validated shipping containers, and documented audit trails are now non-negotiable legal mandates across global healthcare procurement networks.
The final implementation phases of the Drug Supply Chain Security Act (DSCSA) in the United States and similar track-and-trace directives in Europe (FMD) demand interoperable, digital package tracing down to the unit level. Freight forwarders must integrate seamlessly with enterprise ERP and WMS databases to preserve chain of custody and chain of identity.
To outpace supply chain volatility, bio-pharma and healthcare procurement executives are adopting forward-looking strategies focused on resilience, real-time data, and sustainability.
Static data loggers evaluated after delivery are no longer sufficient. Enterprise procurement now demands active IoT loggers broadcasting location, internal/external temperature, tilt, light exposure, and humidity via 5G/satellite to enable proactive in-transit interventions.
To reduce transit lead times and mitigate geopolitical bottlenecks, healthcare organizations are establishing dual-sourcing procurement models, pairing Asian manufacturing with nearshore production hubs in Mexico, Central Europe, and domestic US warehousing.
ESG initiatives are prompting buyers to shift from single-use EPS (Expanded Polystyrene) containers to recyclable Phase Change Materials (PCMs) and vacuum-insulated panel (VIP) reverse-logistics rental programs, reducing landfill waste and carbon footprint.
Machine learning models now analyze weather anomalies, airport ramp congestion, customs hold probabilities, and flight availability to dynamically select freight lanes with the lowest risk of temperature excursion.
SHIPIT Logistics® combines direct ocean carrier contracts for reefer space with premier air freight allocations. With our own temperature-controlled handling protocols, dual-coast U.S. transloading warehouses, and verified partner network spanning 150+ countries, we deliver unmatched reliability for high-value healthcare assets. Whether shipping frozen plasma via ocean reefer or emergency vaccines via expedited air cargo, our team manages every leg with precision.
Verify our credentials with federal authorities. SHIPIT Logistics operates with complete compliance transparency across every transport mode.
004869, License# 001803011344800122629896, MC-910043, FF# 53067
Temperature-controlled transportation historically generates high energy consumption due to active refrigeration units and non-recyclable insulating packaging. SHIPIT Logistics works directly with pharmaceutical procurement leads to engineer eco-efficient cold chain workflows that protect both sensitive products and planet Earth.
Transitioning ambient bio-pharma from air to validated ocean reefer containers.
Reverse logistics management for reusable PCM thermal containers.
Comprehensive shipment CO2e tracking for corporate ESG audits.
ESG Compliance Guarantee: Ask your SHIPIT representative for verified carbon output reporting and certified carbon offset programs for all your air and ocean healthcare shipments.
In-depth answers to common questions asked by global healthcare buyers, pharmaceutical supply chain managers, and medical device importers.
We guarantee thermal integrity by conducting rigorous pre-shipment lane risk assessments, utilizing validated packaging systems (active containers like Envirotainer/CSafe or passive phase-change material configurations), and placing real-time IoT loggers in cargo units. Our GDP-trained control tower monitors temperature, ambient pressure, location, and light intrusion 24/7. In the event of an ambient delay or flight disruption, our global port agents trigger pre-approved Standard Operating Procedures (SOPs), including dry ice replenishment, liquid nitrogen top-ups, or plug-in reefer staging at licensed airport cold stores.
A qualified healthcare freight forwarder must operate under Good Distribution Practice (GDP) guidelines (WHO Annex 5 / EU GDP 2013/C 343/01). Additionally, for air cargo in the United States, the forwarder should be a TSA-approved Indirect Air Carrier (IAC) and an IATA/CNS certified cargo agent with Dangerous Goods (DG) authorization. For ocean shipping, an FMC Ocean Transportation Intermediary (OTI/NVOCC) license is required. SHIPIT Logistics holds all these credentials (FMC Org# 004869, IATA/CNS# 01134480012, TSA IAC, USDOT# 2629896), guaranteeing full legal compliance and audit capability.
Customs delays are prevented by conducting thorough pre-clearance audits of all commercial documentation, HTS classification, FDA Product Codes, and Manufacturer Identification (MID) numbers prior to vessel departure or air cargo tender. SHIPIT’s in-house customs brokerage team files FDA Prior Notice electronically and resolves potential Import Alerts or DEA permit verifications before the cargo arrives at the port of entry. This proactive approach eliminates tarmac holds and warehouse storage fees for time-sensitive healthcare freight.
Active systems use powered mechanical refrigeration or heating units (such as Envirotainer, CSafe, or RKN units) powered by onboard batteries to maintain strict internal temperatures regardless of external ambient weather. Active systems are ideal for large-volume bulk shipments and high-risk air lanes. Passive systems rely on pre-conditioned Phase Change Materials (PCMs), Vacuum Insulation Panels (VIPs), dry ice, or gel packs to maintain thermal boundaries without external power for specified duration windows (e.g., 72 to 144 hours). SHIPIT evaluates shipment value, volume, route complexity, and cost parameters to recommend the optimal packaging mode.
SHIPIT Logistics maintains fully certified Hazmat specialists trained under IATA, IMDG, and DOT 49 CFR regulations. We handle Class 6.2 Infectious Substances (Category A UN2814/UN2900 and Category B UN3373) as well as Class 9 Dangerous Goods (UN1845 Dry Ice and UN3481 Lithium Batteries contained in medical devices). We inspect UN-approved triple-packaging configurations, ensure correct hazard labeling and Shipper’s Declaration for Dangerous Goods (DGD) documentation, and coordinate with compliant air carriers equipped for dangerous goods transport.
If an IoT logger alerts our 24/7 Control Tower of a temperature variation approaching warning thresholds, our immediate response protocol is initiated. This includes notifying the carrier to check reefer power plugs, dispatching local airport agents to transfer cargo to climate-controlled cold rooms (2°C–8°C or 15°C–25°C), or executing dry ice re-topping at pre-designated transit stations. Simultaneously, a formal Deviation Report and Root Cause Analysis (RCA) are initiated in accordance with GDP quality control requirements to provide your Quality Assurance (QA) team with complete transparency.
Yes. SHIPIT offers specialized clinical trial logistics, managing the door-to-door transit of Investigational Medicinal Products (IMPs), clinical trial supplies, placebos, diagnostic kits, and patient specimens. We support single-blind and double-blind trial distribution requirements, temperature-monitored reverse logistics for unused study drugs, and white-glove Direct-to-Patient (DTP) delivery options adhering strictly to patient privacy regulations and investigator site schedules.
The Drug Supply Chain Security Act (DSCSA) mandates full interoperable, electronic tracing of prescription drugs as they move through the distribution pipeline in the United States. International procurement teams must ensure that overseas suppliers, freight forwarders, and 3PL warehousing partners can exchange 2D data matrix serialization data (Transaction Information, Transaction History, and Transaction Statement). SHIPIT’s systems integrate with digital track-and-trace platforms to maintain an unbroken data trail alongside physical cargo movement.
Speak directly with our GDP-trained healthcare logistics experts with over 50 years of international trade experience.